No national formulary in eight years

The last time the drug administration updated the national formulary was back in 2006. Over these past eight years, many new drugs have come into the market; but none have been incorporated into the formulary.

The Bangladesh National Formulary (BNF) is a comprehensive list of all the drugs available in the market. The list, prepared by the Directorate General of Drug Administration (DGDA), helps doctors to know the efficacy, price, risks and other information about a drug before prescribing it.

Doctors said the lack of an updated BNF has made them dependent on the literature provided with the drugs by the pharmaceutical companies and also the briefing they get from the representatives to know details about many drugs, especially those that hit the market after 2006.

Experts said if the government did not maintain a regularly updated guideline encompassing all the drugs in the market, the risks associated with irrational use of drugs would keep in rising.

The government has so far prepared three BNFs: 2001, 2003 and 2006.

After all these years, the DGDA reformed the BNF Committee and formed three other committees in September 2013 to update the formulary.

Selim Barami, a director of DGDA, told the Dhaka Tribune that the four committees have been working full time and hope to bring the list out soon, although he cannot specify any time at present.

Sources say the committees are going to sit in a meeting today to discuss the progress made.

Seeking anonymity, a high-ranking official of the DGDA told the Dhaka Tribune that the rise in misuse is a result of the fact that the formulary had not been updated in so many years which means that there has been no standard prescription guideline for many drugs.

According to the DGDA’s latest annual report, a total of 258 allopathic companies have been producing and marketing 22,000 kinds of drugs in the country. Additionally, there are 268 unani, 79 homeopath and 25 herbal drug producers.

Professor Dr Rashid-e-Mahbub, president of Health Rights Movement Bangladesh, said it is the government’s duty to prepare an updated list of available drugs of different pharmaceuticals companies.

“An absence of such a comprehensive list is dangerous for public health,” he said.

Prof Dr Sayedur Rahman, registrar of BSMMU, said: “New drugs are regularly coming into the market. So, it is not possible for doctors to remember everything about those drugs.”

Referring to the World Health Organization, he said the rational use of 50% of the drugs has been hampered by incorrect prescriptions, dispensing and consumption.